GlaxoSmithKline
-$0.75 (-1.85%) As of 5:44 PM UTC today
Why Robinhood?
You can buy or sell GSK and other stocks, options, and ETFs commission-free!
About GSK
GlaxoSmithKline plc, also called GlaxoSmithKline, is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare.
CEO
Emma N. Walmsley
Employees
94,066
Headquarters
Middlesex, Greater London
Founded
1999
GSK Key Statistics
Market Cap
99.63B
Price-Earnings Ratio
14.88
Dividend Yield
5.28
Average Volume
4.35M
High Today
$40.13
Low Today
$39.78
Open Price
$39.96
Volume
8.57M
52 Week High
$42.40
52 Week Low
$33.26
GSK News
Bloomberg20h
Glaxo-Backed Lyell Immunopharma Wobbles in Trading Debut
(Bloomberg) -- Lyell Immunopharma Inc., a cancer drug developer backed by GlaxoSmithKline Plc and Celgene Corp., seesawed in its trading debut after raising $42
Analyst Ratings
52%
of 25 ratings
Buy
36%
Hold
52%
Sell
12%
GSK Earnings
$0.00
$0.29
$0.58
$0.87
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Jul 28
